Table 2.
Comparison between the Chronic Hepatitis and Cirrhosis Groups
| Variable | Normal range |
CH (n=48) | LC | |||
|---|---|---|---|---|---|---|
| LC total (n=48) | Child-Pugh A (n=25) | Child-Pugh B (n=12) | Child-Pugh B&C (n=23) | |||
| AsAGP, μg/mL | <1.33 | 1.42±0.29 | 1.83±0.64 | 1.68±0.66 | 1.88±0.40 | 1.98±0.61 |
| MRE, kPa | <2.0 | 2.60±0.65 | 6.62±1.34 | 6.17±1.14 | 7.43±1.55 | 7.11±1.41 |
| MRI-PDFF, % | - | 9.43±9.57 | 4.69±5.78 | 2.74±1.40 | 5.88±6.11 | 6.80±7.77 |
| AST/ALT ratio | - | 1.58±0.89 | 3.02±2.53 | 2.10±0.91 | 2.90±1.49 | 4.02±3.27 |
| Bilirubin, mg/dL | 0.2–1.4 | 0.75±0.30 | 2.45±2.14 | 1.22±0.49 | 3.23±2.38 | 3.79±2.44 |
| Albumin, mg/dL | 3.5–5.0 | 4.33±0.37 | 3.45±0.67 | 3.92±0.40 | 3.07±0.65 | 2.93±0.52 |
| PT, INR | <1.7 | 1.05±0.07 | 1.37±0.35 | 1.15±0.13 | 1.53±0.35 | 1.61±0.35 |
| Platelet, ×103/mm3 | 150–450 | 224.33±67.43 | 110.02±55.92 | 127.4±54.24 | 90.33±31.77 | 92.00±58.09 |
Data are presented as mean±SD.
CH, chronic hepatitis; LC, liver cirrhosis; AsAGP, asialo α1-acid glycoprotein; MRE, magnetic resonance elastography; MRI-PDFF, magnetic resonance imaging proton density fat fraction; AST, aspartate aminotransferase; ALT, alanine aminotransferase; PT, prothrombin time; INR, international normalized ratio.